インドの医薬品市場:ジェネリック医薬品、OTC医薬品、特許薬、バイオシミラー...市場調査レポートについてご紹介

【英文タイトル】Indian Pharmaceutical Market Forecast 2016-2026

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Report Overview
1.1 The Indian Pharmaceutical Market Overview
1.2 Indian Pharmaceutical Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain

2. Indian Healthcare: Overview
2.1 India: Demographic Indicators Overview
2.2 Indian Healthcare system: Overview
2.2.1 Rashtriya Swasthya Bima Yojana – Bringing Healthcare Coverage to India’s Poorest Workers
2.3 Analysis of India’s Healthcare Expenditure
2.4 State Bodies regulating the Indian Pharmaceutical Market
2.4.1 The Drugs and Cosmetics Act, 1940

3. Indian Pharmaceutical Market: Discussions and Predictions 2016-2026
3.1 Indian Pharmaceutical Market: The Third Biggest Market in the World by Volume, 2015
3.2 Indian Pharmaceutical Market: Overall Revenue Forecast 2016-2026

4. Medical Treatment Needs in India, 2016-2026
4.1 Disease Prevalence in India, 2016-2026
4.2 Disease Incidence in India, 2016-2026
4.3 Disease Mortality Rates in India, 2016-2026
4.3.1 Top Causes of Death in India
4.3.2 Top Causes of Death in India: Mortality Projections, 2016-2026

5. Indian Pharmaceutical Market: Leading Therapeutic Areas, 2016-2026
5.1 Leading Therapeutic Areas in the Indian Pharmaceutical Market: Overview, 2015
5.2 Indian Pharmaceutical Market: Leading Therapeutic Areas Forecasts, 2016-2026
5.3 Infectious Disease Therapeutics: Overview, 2015
5.3.1 Infectious Disease Drugs Market: Forecast, 2016-2026
5.3.2 Diarrheal Diseases Responsible for Over Half a Million Annual Deaths, 2015
5.3.3 Lower Respiratory Tract Infections Among Leading Causes of Death in 2015
5.3.4 Tuberculosis Still Rife in India
5.3.5 Malaria, Risk and Opportunity
5.3.6 HIV in India: Growing Therapeutic Area Worth Watching
5.3.7 Drivers and Restraints for the Infectious Diseases Pharmaceutical Segment, 2015-2026
5.4 Cardiovascular Therapeutic Segment: Overview, 2015
5.4.1 Cardiovascular Disease – India’s Leading Cause of Death, 2015
5.4.2 Cardiovascular Drugs Market: Forecast, 2016-2026
5.4.3 Drivers and Restraints for the Indian Cardiovascular Drugs Market, 2015-2026
5.5 Gastro-Intestinal Therapeutic Segment: Overview, 2015
5.5.1 Gastro-Intestinal Drugs Market: Forecast, 2016-2026
5.5.2 Gastro-Intestinal Drugs in India: Challenges and Opportunities
5.5.3 Drivers and Restraints for the Gastro-Intestinal Drugs Segment, 2015
5.6 Respiratory Therapeutic Segment: Overview, 2015
5.6.1 Respiratory Disease Drugs Market: Forecast, 2016-2026
5.6.2 Drivers and Restraints for the Respiratory Diseases Segment, 2015
5.7 Pain Relief / Analgesics Therapeutic Segment: Overview, 2015
5.7.1 Pain Relief / Analgesics Drugs Market: Forecast, 2016-2026
5.7.2Drivers and Restraints for the Pain Relief / Analgesics Drugs Segment, 2015
5.8 Diabetes Therapeutic Segment: Overview, 2015
5.8.1 Diabetes Drugs Market: Forecast, 2016-2026
5.8.2 Drivers and Restraints for the Diabetes Drugs Segment, 2015
5.9 Vitamins / Minerals / Nutrients Therapeutic Segment: Overview, 2015
5.9.1 Vitamins / Minerals / Nutrients Drugs Market: Forecast, 2016-2026
5.9.2 Vitamins / Minerals / Nutrients in India: Challenges and Opportunities
5.9.3 Drivers and Restraints for the Vitamins / Minerals / Nutrients Drugs Segment, 2015
5.10 Dermatological Therapeutic Segment: Overview, 2015
5.10.1 Dermatological Drugs Market: Forecast, 2016-2026
5.10.2 Drivers and Restraints for the Dermatological Drugs Segment, 2015
5.11 Central Nervous System (CNS) Therapeutics: Overview, 2015
5.11.1 CNS Drugs Market: Forecast, 2016-2026
5.11.2 Intentional Injury Among the Top 10 Leading Causes of Death, 2015:
5.11.3 India’s Aging Population: Driver for the CNS Segment
5.11.4 Drivers and Restraints for the CNS Drugs Segment, 2015
5.12 Gynaecological Treatment Market Overview: 2015
5.12.1 Infant Mortality Still High in India
5.12.2 Indian Gynaecological Treatments Market: Forecast, 2016-2026
5.12.3 Drivers and Restraints for the Gynaecological Segment, 2015
5.13 Other Pharmaceutical Products Market Overview: 2015
5.13.1 Incidence of Cancer in India is Rising
5.13.2 Indian Other Treatments Market: Forecast, 2016-2026

6. Indian Pharmaceutical Market: Leading Drug Types, 2016-2026
6.1 Drug Types in the Indian Market: Overview, 2015
6.2 Growth Forecasts for Leading Drug Types in India, 2016-2026
6.3 Generic Drugs Dominate the Indian Pharmaceutical Market
6.3.1 Indian Generics: Overview, 2015
6.3.2 Indian Generic Drugs Market: Forecast, 2016-2026
6.3.3 Branded Generics Preferred by Many Indian Patients
6.3.4 Drivers and Restraints for the Generic Drug Market in India, 2015
6.4 Indian Over-The-Counter (OTC) Drugs Market: Overview, 2015
6.4.1 Indian OTC Market: Forecast, 2016-2026
6.4.2 Drivers and Restraints of the Indian OTC Market
6.5 Indian Patented Drugs Market: Overview, 2015
6.5.1 Indian Patented Drugs Market: Forecasts, 2016-2026
6.5.2 Drivers and Restraints for the Indian Patented Drugs Market
6.6 Indian Biosimilar Drugs, 2015
6.6.1 Indian Biosimilar Drugs Market: Forecast, 2016-2026
6.6.2 A Number of Blockbuster Drugs Coming Off-Patent Over the Next Decade
6.6.3 Drivers and Restraints of the Indian Biosimilar Drugs Market

7. The Leading Companies in the Indian Pharmaceutical Market, 2016-2026
7.1 Indian Pharmaceutical Market Overview
7.1.1 Indian Pharmaceutical Patent Law and the Effect on Big Pharmaceutical Companies
7.2 Top 50 Domestic Indian Pharmaceutical Companies, 2015
7.3 Sun Pharmaceuticals Industries Limited
7.3.1 Sun Pharma: Global Presence
7.3.1.1 Sun Pharmaceutical Sales by Region, 2015
7.3.2 Sun Pharmaceuticals Business Performance 2006-2015
7.3.3 Sun Pharmaceutical: Ranbaxy Laboratories Acquisition is the Largest Ever Deal Made by an Indian Pharmaceutical Company
7.3.3.1 Other Major M&A Activity
7.4 Abbott Healthcare Private Limited (Abbott India)
7.4.1 Abbott India: Business Performance 2006-2015
7.4.2 Abbott India: Key Brands in the Indian Pharmaceutical Market
7.4.3 Abbott India: Major and Recent M&A Activity
7.5 Cipla Ltd.
7.5.1 Cipla: Business Performance 2006-2015
7.6 Cadila Healthcare Limited
7.6.1 Cadila: Business Performance 2006-2015
7.6.2 Cadila Healthcare Revenue by Therapeutic Area 2015
7.6.3 Cadila Healthcare Revenue by Business Area 2015
7.7 GlaxoSmithKline Pharmaceuticals Limited
7.7.1 GlaxoSmithKline India: Business Performance 2006-2015
7.7.2 GlaxoSmithKline India: Revenue by Product Type, 2015
7.8 Pfizer Limited. India
7.8.1 Pfizer India: Business Performance 2006-2015
7.7.2 Pfizer India: Revenue by Product Type, 2015
7.9 Lupin
7.9.1 Lupin: Business Performance 2006-2015
7.9.2 Lupin Revenue by Therapeutic Area, 2015

8. Qualitative Analysis of the Indian Pharmaceutical Market, 2015
8.1 Indian Pharmaceutical Market: Drivers and Restraints
8.2 SWOT Analysis of the Indian Pharmaceutical Market, 2015-2026
8.3 Strengths
8.3.1 Increasing Investment in the Healthcare System
8.3.2 The Disease Burden and GDP Both Growing
8.3.3 India’s Population Set to Become the World’s Largest by 2030
8.3.4 India Popular for Pharmaceutical Outsourcing
8.4 Weaknesses
8.4.1 Stringent Pricing Regulations Hit the Indian Pharmaceutical Market
8.4.2 Poor Infrastructure Threatens to Hinder Market Potential
8.4.3 Intense Competition Driving Down Drug Prices
8.5 Opportunities
8.5.1 Global Demand for Generics Rising
8.5.2 National Rural Health Mission Driving Healthcare Access in Rural Areas
8.5.3 Significant Investment from MNCs Expected
8.5.4 Innovative Biotechnology Sector Set to Capitalise on Patent Expiries
8.6 Threats
8.6.1 Rise of Other Low-Cost Generic Exporters
8.6.2 Will the Indian Government Stick to Increasing Healthcare Expenditure?
8.6.3 Recent Warnings and Export Bans from Regulatory Bodies Hit Confidence in Indian Pharmaceuticals
8.7 Porter’s Five Forces Analysis of the Indian Pharmaceutical Market
8.7.1 Rivalry Among Competitors [High]
8.7.2 Threat of New Entrants [Low]
8.7.3 Power of Suppliers [Medium]
8.7.4 Power of Buyers [High]
8.7.5 Threat of Substitutes [Low]

9. Conclusion
9.1 The Indian Pharmaceutical Market: Growing Global Market Share
9.2 Indian Pharmaceutical Market: Chronic Diseases Becoming Increasingly Prevalent
9.3 Commercial Drivers of the Indian Pharmaceutical Market
9.4 Commercial Restraints of the Indian Pharmaceutical Market
9.5 Concluding Remarks

10. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form


【レポート販売概要】

■ タイトル:インドの医薬品市場:ジェネリック医薬品、OTC医薬品、特許薬、バイオシミラー
■ 英文:Indian Pharmaceutical Market Forecast 2016-2026
■ 発行日:2015年12月
■ 調査会社:visiongain
■ 商品コード:VGAIN5122116
■ 調査対象地域:インド
  • オールテレーン車両の世界市場2016-2020:UTV、ATV、スノーモービル
    About All-Terrain Vehicles ATV (also known as a quad, quad bike, three-wheeler, four-wheeler, or quadricycle) are off-highway recreational vehicles specifically designed for a wider variety of terrains such as a combination of land, water, snow, ice, marsh, swampland, and natural terrain. The off-road segment of recreational activities is one of the fastest growing markets compared with the conven …
  • 世界の通信産業におけるFPGA市場動向(2012-2016)
    TechNavio's analysts forecast the Field Programmable Gate Array (FPGA) market in the Global Telecom industry to grow at a CAGR of 9.1 percent over the period 2012-2016. One of the key factors contributing to this market growth is the unlimited demand for bandwidth in wireless networks. The FPGA Market in the Global Telecom industry has also been witnessing an increased preference for greener techn …
  • 世界のナノ複合材料ジルコニア市場2015
    The Global Nano Composite Zirconia Industry Report 2015 is a professional and in-depth study on the current state of the Nano Composite Zirconia industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Nano Composite Zirconia market analysis is provided for the international markets including development t …
  • Constellation Energy Partners LLC:石油・ガスの開発・生産動向及びコスト分析- Q2, 2013
    Constellation Energy Partners LLC Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Constellation Energy Partners LLC Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The repor …
  • 発現ベクターの世界市場:細菌発現ベクター、哺乳類発現ベクター、昆虫発現ベクター、酵母発現ベクター
    The expression vectors market is expected to reach $317.1 million by 2020 from $242.7 million in 2015, growing at a CAGR of 5.5% from 2015 to 2020. The market is categorized on the basis of host type, application, end user, and region. The application market includes therapeutic, research, and industrial applications. The therapeutic applications segment is expected to grow at the highest CAGR in …
  • 非小細胞肺癌治療薬の世界市場2019-2023
    About this market The increasing prevalence and incidence of non-small cell lung cancer are one of the primary factors driving the global non-small cell lung cancer drugs market growth. The growing risk factors such as cigarette smoking, air pollution, secondary smoking, and occupational exposure is increasing the incidence of non-small cell lung cancer across the world. This will lead to an incre …
  • 貨物輸送の世界市場:液体貨物、バラ積み乾貨物、一般貨物、コンテナー貨物
    In the past decade it has been seen that world economic activity, trade liberalization and current growth in Asian economies is the main driving cause in global marine industry. In the upcoming years, the industry is projected to get benefit from improving trade levels with greater demand from the logistics and shipping sectors. Trade between Asian countries and the rest of the world is expected t …
  • 通年性アレルギー性鼻炎(Perennial Allergic Rhinitis)の治療薬パイプライン動向(2015年上半期版)
    Perennial Allergic Rhinitis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Perennial Allergic Rhinitis - Pipeline Review, H1 2015’, provides an overview of the Perennial Allergic Rhinitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Perennial Allergic Rhinitis, complete with comparative analysis at various stages, therapeut …
  • トリクレンの世界市場
    Trichlorethylene (CAS 79-01-6) Market Research Report 2014 presents comprehensive data on trichlorethylene markets globally and regionally (Europe, Asia, North America etc.) The report includes trichlorethylene description, covers its application areas and related patterns. It overviews trichlorethylene market, names trichlorethylene producers and indicates its suppliers. Besides, the report provi …
  • 2014 World Animal Health Market Dynamics, Trends, and Leading Supplier Marketing Tactics and Technological Know-How
    This new 80-pages report from Venture Planning Group analyzes marketing tactics and technological know-how of the world’s leading animal health companies, including: Five-year forecasts for: - Major market segments - Key geographic regions Assessment of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, …
  • 世界の急速熱処理装置市場2015
    The Global Rapid Thermal Processing Equipment Industry Report 2015 is a professional and in-depth study on the current state of the Rapid Thermal Processing Equipment industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Rapid Thermal Processing Equipment market analysis is provided for the international …
  • Arsenal Energy Inc.:石油・ガスの開発・生産動向及びコスト分析- Q2, 2013
    Arsenal Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Arsenal Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
  • AR装置及びVR装置の世界市場2017-2021
    About Augmented Reality and Virtual Reality Gear AR is a technology that diminishes the line between reality and computer-generated graphics. It enhances a user's experience, in terms of what the user sees, hears, feels, and smells. VR creates an immersive computer-generated environment that is like the real word. VR technology uses computers to develop a simulated artificial environment. With VR, …
  • 電子棚ラベルの世界市場展望2017-20276
    According to Stratistics MRC, the Global Electronic Shelf Label Market is accounted for $435.93 million in 2017 and is expected to reach $2,721.70 million by 2026 growing at a CAGR of 22.6% during the forecast period. Some of the key factors influencing the market growth include increased operational efficiency with real-time product positioning, NFC penetration in POS and Smartphones and increase …
  • 頭蓋内圧亢進治療のグローバル臨床試験動向(2014年H2)
    Intracranial Hypertension Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Intracranial Hypertension Global Clinical Trials Review, H2, 2014" provides data on the Intracranial Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Intracranial Hypertension. It includes an overview of the trial …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。